Rafferty Asset Management, LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1389426 New York, NY

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$830,163

-$297,009 QoQ

Shares Held

221,377

-7.7% QoQ

Ownership

0.102%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#55

of 178 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. CTMX ranks #99 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$830,163	221,377	-7.7%	Shares	Sole	2026-08-14
2026-03-31	$1,127,172	239,824	-12.3%	Shares	Sole	2026-05-15
2025-12-31	$1,165,467	273,584	+79.6%	Shares	Sole	2026-02-13
2021-12-31	$659,757	152,369	-3.7%	Shares	Sole	2022-02-10
2021-09-30	$805,752	158,301	-18.9%	Shares	Sole	2021-11-10
2021-06-30	$1,236,160	195,286	+20.1%	Shares	Sole	2021-08-10
2021-03-31	$1,257,338	162,657	+873.6%	Shares	Sole	2021-05-10
2020-12-31	$109,430	16,707	-65.8%	Shares	Sole	2021-02-10
2020-09-30	$324,573	48,808	+120.2%	Shares	Sole	2020-11-13
2020-06-30	$184,676	22,170	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.